BMP10 is essential for maintaining cardiac growth during murine cardiogenesis

Development

Volumn 131, Issue 9, 2004, Pages 2219-2231

  Chen, Hanying ^a   Shi, Shu ^a   Acosta, Lourdes ^b   Li, Weiming ^a   Lu, Jonathan ^c   Bao, Shideng ^d   Chen, Zhuang ^a   Yang, Zuocheng ^a   Schneider, Michael D ^e   Chien, Kenneth R ^c   Conway, Simon J ^a   Yoder, Mervin C ^a   Haneline, Laura S ^a   Franco, Diego ^b   Shou, Weinian ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF JAÉN   (Spain)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

BMP10; Cardiac growth; Compaction; MEF2C; NKX2.5; p57kip2; Ventricular trabeculation

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 10; CELL CYCLE PROTEIN; PROTEIN P57; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; GENE DELETION; GENE EXPRESSION; HEART DEVELOPMENT; HEART MUSCLE CELL; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MOLECULAR CLONING; MOLECULAR MECHANICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYCLIN-DEPENDENT KINASE INHIBITOR P57; EMBRYO; GENE EXPRESSION PROFILING; GESTATIONAL AGE; HEART; HEART DEFECTS, CONGENITAL; HUMANS; MICE; MICE, KNOCKOUT; MORPHOGENESIS; MYOCYTES, CARDIAC; NUCLEAR PROTEINS; TACROLIMUS BINDING PROTEIN 1A;

ANIMALIA; MURINAE;

EID: 2042462926     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: 10.1242/dev.01094     Document Type: Article

References (50)

1. Andree, B., Duprez, D., Vorbusch, B., Arnold, H. H. and Brand, T. (1998). BMP-2 induces ectopic expression of cardiac lineage markers and interferes with somite formation in chicken embryos. Mech. Dev. 70, 119-131.
2. Bao, S., Shen, X., Shen, K., Liu, Y. and Wang, X. F. (1998). The mammalian Rad24 homologous to yeast Saccharomyces cerevisiae Rad24 and Schizosaccharomyces pombe Rad17 is involved in DNA damage checkpoint. Cell Growth Differ. 9, 961-967.
3. Barron, M., Gao, M. and Lough, J. (2000). Requirement for BMP and FGF signaling during cardiogenic induction in non-precardiac mesoderm is specific, transient, and cooperative. Dev. Dyn. 218, 383-393.
4. Black, B. L. and Olson, E. N. (1999). Control of cardiac development by the MEF2 family of transcription factors. In Heart Development (ed. R. P. Harvey and N. Rosenthal), pp. 131-142. San Diego: Academic Press.
5. Chen, F., Kook, H., Milewski, R., Gitler, A. D., Lu, M. M., Nazarian, R., Schnepp, R., Jen, K., Biben, C., Runke, G., Mackay, J. P., Novotny, J., Schwatz, R. J., Harvey, R. P., Mullins, M. C. and Epstein, J. A. (2002). Hop is an unusual homeobox gene that modulates cardiac development. Cell 110, 713-723.
6. Conway, S. J., Henderson, D. J. and Copp, A. J. (1997). Pax3 is required for cardiac neural crest migration in the mouse: evidence from the splotch (Sp2h) mutant. Development 124, 505-514.
7. Ducy, P. and Karsenty, G. (2000). The family of bone morphogenetic proteins. Kidney International 57, 2207-2214.
8. Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A. and Breitman, M. L. (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8, 1897-1909.
9. Durocher, D., Chen, C-Y., Ardati, A., Schwartz, R. J. and Nemer, M. (1996). The atrial natriuretic factor promoter is a downstream target for Nkx2.5 in the myocardium. Mol. Cell Biol. 16, 4648-4655.
10. Dusek, J., Ostadal, B. and Duskova, M. (1975). Postnatal persistence of spongy myocardium with embryonic blood supply. Arch. Pathol. 99, 312-317.
11. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J. and Moore, M. W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
12. Franco, D. and Icardo, J. M. (2001). Molecular characterization of the ventricular conduction system in the developing mouse heart: topographical correlation in normal and congenitally malformed hearts. Cardiovasc. Res. 49, 417-429.
13. Franco, D., deBoer, P. A., deGier-de Vries, C., Lamers, W. H. and Moorman, A. F. (2001). Methods on in situ hybridization, immunohistochemistry and beta-galactosidase reporter gene detection. Eur. J. Morphol. 39, 169-191.
14. Gassmann, M., Casagranda, F., Oriori, A. Simon, H., Lai C. and Klein, R. and Lemek, G. (1995). Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378, 390-394.
15. Gaussin, V., Van de Putte, T., Mishina, Y., Hanks, M. C., Zwijsen, A., Huylebroeck, D., Behringer, R. R. and Schneider, M. D. (2002). Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenctic protein receptor ALK3. Proc. Natl. Acad. Sci. USA 99, 2878-2883.
16. Haneline, L. S., Li, X., Ciccone, S. L. M., Hong, P., Yang, Y., Lee, S-H., Orazi, A., Srour, E. F. and Clapp, D. W. (2003). Retroviral-mediated expression of recombinant Fancc enhances the repopulating ability of Fancc-/- hematopoietic stem cells and decreases the risk of clonal evolution. Blood 101, 1299-1307.
17. Harvey, R. P., Biben, C. and Elliott, D. A. (1999). Transcriptional control and pattern formation in the developing vertebrate heart: studies on NK-2 class homeodomain factors. In Heart Development (ed. R. P. Harvey and N. Rosenthal), pp. 111-129. San Diego: Academic Press.
18. Icardo, J. M. (1984). The growing heart: an anatomical perspective. In Growth of the Heart in Health and Disease (ed. R. Zak), pp. 41-79. New York: Raven Press.
19. Ichida, F., Tsubata, S., Bowles, K. R., Haneda, N., Uese, K., Miyawaki, T., Dreyer, W. J., Messina, J., Li, H., Bowles, N. E. and Towbin, J. A. (2001). Novel gene mutations in patients with left ventricular noncompaction or Bath Syndrome. Circulation 103, 1256-1263.
20. Kim, R. Y., Robertson, E. J. and Solloway, M. J. (2001). Bmp6 and Bmp7 are required for cushion formation and septation in the developing mouse heart. Dev. Biol. 235, 449-466.
21. Kochilas, L. K., Li, J., Jin, F., Buck, C. A. and Epstein, J. A. (1999). P57kip2 expression is enhanced during mid-cardiac murine development and is restricted to trabecular myocardium. Pediatr. Res. 45, 635-642.
22. Lee, K. F., Simon, H., Chen, H., Bates, B., Hung, M. C. and Hauser, C. (1995). Requirement for neuregulin receptor ErbB2 in neural and cardiac development. Nature 378, 394-398.
23. Liberatore, C. M., Searcy-Schrick, R. D., Vincent, E. B. and Yutzey, K. E. (2002). Nkx-2.5 gene induction in mice is mediated by a Smad concensus regulatory region. Dev. Biol. 244, 243-256.
24. Lien, C-L., McAnally, J., Richardson, J. A. and Olson, E. N. (2002). Cardiac-specific activity of an NKX2-5 enhancer requires an evolutionarily conserved Smad binding site. Dev. Biol. 244, 257-266.
25. Massague, J. and Chen, Y. G. (2000). Controlling TGF-beta signaling. Genes Dev. 14, 627-644.
26. Meyer, D. and Birchmeier, C. (1995). Multiple essential functions of neuregulin in development. Nature 378, 386-390.
27. Millauer, B., Wizigmann-Voos, S., Schnurch, H., Martinez, R., Moller, N. P., Risau, W. and Ullrich, A. (1993). High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72, 835-846.
28. Moorman, A. F. M. and Lamers, W. H. (1999). Development of the conduction system of the vertebrate heart. In Heart Development. (ed. R. P. Harvey and N. Rosenthal), pp. 195-207. San Diego: Academic Press.
29. Nakajima, Y., Yamagishi, T., Hokari, S. and Nakamura, H. (2000). Mechanisms involved in valvuloseptal endocardial cushion formation in early cardiogenesis: roles of transforming growth factor (TGF)-beta and bone morphogenetic protein (BMP). Anat. Rec. 258, 119-127.
30. Nakayama, T., Cui, Y. and Christian, J. L. (2000). Regulation of BMP/Dpp signaling during embryonic development. Cell Mol. Life Sci. 57, 943-956.
31. Neuhaus, H., Rosen, V. and Thies, R. S. (1999). Heart specific expression of mouse BMP-10 a novel member of the TGF-β superfamily. Mech. Dev. 80, 181-184.
32. Palmer, S., Groves, N., Schindeler, A., Yeoh, T., Biben, C., Wang, C-C., Sparrow, D. B., Barnett, L., Jemkins, N. A., Copeland, N. G., Koentgen, F., Mohum, T. and Harvey, R. P. (2001). The small muscle-specific protein Csl modifies cell shape and promotes myocyte fusion in an insulin-like growth factor 1-dependent manner. J. Cell Biol. 153, 985-997.
33. Pashmforoush, M., Lu, J. T., Chen, H., St Amand, T., Kondo, R., Pradervand, S., Evans, S. M., Clark, R., Feramisco, J. R., Giles, W., Ho, S. Y., Benson, W. D., Silberbach, M., Shou, W. and Chien, K. R. (2004). Defects in Nkx 2.5 pathways for ventricular myocytes lineage specification leads to progressive cardiomyopathy and atrioventricular heart block. Cell (in press).
34. Rentschler, S., Zander, J., Meyers, K., France, D., Levine, R., Porter, G., Rivkees, S. A., Morley, G. E. and Fishman, G. I. (2002). Neuregulin-1 promotes formation of the murine cardiac conduction system. Proc. Natl. Acad. Sci. USA 99, 10464-10469.
35. Rumyantsev, P. P. (1991). Growth and hyperplasia of cardiac muscle cells. In Soviet Medical Reviews Supplement series (ed. B. M. Carlson), pp. 12-36. London: Harwood Academic Publishers.
36. Schneider, M. D., Gaussin, V. and Lyons, K. M. (2003). BMP signals for cardiac morphogenesis. Cytokine Growth Factor Rev. 14, 1-4.
37. Schott, J. J., Benson, D. W., Basson, C. T., Pease, W., Silberbach, G. M., Moak, J. P., Maron, B. J., Seidman, C. E. and Seidman, J. G. (1998). Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science 281, 108-111.
38. Schultheiss, T. M., Burch, J. B. and Lassar, A. B. (1997). A role for bone morphogenetic proteins in the induction of cardiac myogenesis. Genes Dev. 11, 451-462.
39. Shin, C. H., Liu, Z-P., Passier, R., Zhang, C-L., Wang, D-Z., Harris, T. M., Yamagishi, H., Richardson, J. A., Childs, G. and Olson, E. N. (2002). Modulation of cardiac growth and development by HOP, an unusual homeodomain protein. Cell 110, 725-735.
40. Shou, W., Aghdasi, B., Armstrong, D. L., Guo, Q., Bao, S., Charng, M-J., Mathews, L. S., Schneider, M. D., Hamilton, S. L. and Matzuk, M. M. (1998). Cardiac defects and altered ryanodine receptor function in mice lacking FKBP12. Nature 391, 489-492.
41. Solloway, M. J. and Robertson, E. J. (1999). Early embryonic lethality in Bmp5; Bmp7 double mutant mice suggests functional redundancy within the 60A subgroup. Development 126, 1753-1768.
42. Srivastava, D. and Olson, E. N. (2000). A genetic blueprint for cardiac development. Nature 407, 221-226.
43. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N. and Yancopoulos, G. D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
44. Wang, T., Donahoe, P. K. and Zervos, A. S. (1994). Specific interaction of type 1 receptor of the TGF-β family with the immunophitin FKBP-12. Science 265, 674-676.
45. Wang, T., Li, B.-Y., Danielson, P. D., Shah, P. C., Rockwell, S., Lechleider, R. J., Martin, J., Manganaro, T. and Donahoe, P. K. (1996).The immunophilin FKBP12 functions as a common inhibitor of the TGFβ family type 1 receptors. Cell 86, 435-444.
46. Winnier, G. E., Kume, T., Deng, K., Rogers, R., Bundy, J., Raines, C., Walter, M. A., Hogan, B. L. and Conway, S. (1999). Roles for the winged helix transcription factors MF1 and MFH1 in cardiovascular development revealed by nonalletic noncomplementation of null alleles. Dev. Biol. 213, 418-431.
47. Yan, Y., Frisen, J., Lee, M. H., Massague, J. and Barbacid, M. (1997). Ablation of the CDK inhibitor p57kip2 results in increased apoptosis and delayed differentiation during development. Genes Dev. 11, 973-983.
48. Zhang, P., Liegeois, N. J., Wong, C., Finegold, M., Hou, H., Thompson, J. C., Silverman, A., Harper, J. W., DePinho, R. A. and Elledge, S. J. (1997). Altered cell differentiation and proliferation in mice lacking p57kip2 indicates a role in Beckwith-Wiedemann syndrome. Nature 387, 151-158.
49. Zhang, P., Wong, C., DePinho, R. A., Harper, J. W and Elledge, S. J. (1998). Cooperation between the Cdk inhibitors p21kip1 andp57kip2 in the control of tissue growth and development. Genes Dev. 12, 3162-3167.
50. Zhang, P., Wong, C., Liu, D., Finegold, M., Harper, J. W. and Elledge, S. J. (1999). p21cip1 and p57kip2 control muscle differentiation at the myogenin step. Genes Dev. 13, 213-224.